ALVO logo

Alvotech

ALVO
Healthcare|Drug Manufacturers - Specialty & Generic|LU
$4.86
+0.31 (+6.81%)
Cash / Share
$0.40
Next Earnings Report
Nov 11, 2026
EPS est. -$0.02 · Revenue est. $134.2M
Financing Filings (last 12 months)
2
Shelf registrations / offering prospectuses — latest Jun 16, 2026 (424B5). Possible dilution.

Upcoming Data Readouts (2)

Jul 2027
Est. completion
P3Diabetic Macular Edema
Clinical Study to Compare Efficacy and Safety of AVT29 and Eylea HD in Participants With Diabetic Macular Edema
NCT07489131n=256
Oct 2027
Est. completion
P1Melanoma
Pharmacokinetic Similarity Study to Compare AVT32-DRL_PB With Keytruda® in Participants With Fully Resected Melanoma
NCT07475572n=120

Recent Press Releases

Alvotech to Present at Upcoming Investor Conferences in November
Nov 2, 2026 · GlobeNewsWire
Alvotech to Report Financial Results for the Nine-Month Period to September 30, 2026
Oct 28, 2026 · GlobeNewsWire
Alvotech receives FDA approval for new SIMLANDI® manufacturing process that more than doubles output per batch
Oct 20, 2026 · GlobeNewsWire
Alvotech and Advanz Pharma announce first known regulatory submission worldwide for proposed biosimilar to Eylea® 8 mg
Oct 14, 2026 · GlobeNewsWire
Alvotech and LOTTE Biologics announce US-based manufacturing agreement to increase global supply
Oct 6, 2026 · GlobeNewsWire
FDA approves additional U.S. manufacturing capacity for SIMLANDI®, Alvotech's biosimilar to Humira®
Oct 5, 2026 · GlobeNewsWire
Alvotech announces FDA acceptance for review of Biologics License Application for AVT80, expanding proposed biosimilar program for Entyvio® to subcutaneous presentations
Aug 31, 2026 · GlobeNewsWire
Alvotech to present at upcoming investor conferences in September
Aug 27, 2026 · GlobeNewsWire
Alvotech Announces Licensing and Commercialization Agreement with Lotus Pharmaceutical for proposed biosimilars to durvalumab and emicizumab in the U.S. and Selected Asian Markets
Aug 21, 2026 · GlobeNewsWire
Alvotech Announces Financial Results for the First Half of 2026 and Provides a Business Update
Aug 19, 2026 · GlobeNewsWire

SEC Filings (72)

Last two years from EDGAR. Insider Form 4s are on the Ownership tab.

FiledFormWhat it isLinks
Oct 20, 20266-KForeign issuer reportDocumentIndex
Oct 14, 20266-KForeign issuer reportDocumentIndex
Oct 7, 20266-KForeign issuer reportDocumentIndex
Oct 5, 20266-KForeign issuer reportDocumentIndex
Aug 31, 20266-KForeign issuer reportDocumentIndex
Aug 21, 20266-KForeign issuer reportDocumentIndex
Aug 19, 20266-KForeign issuer reportDocumentIndex
Jul 29, 20266-KForeign issuer reportDocumentIndex
Jul 1, 20266-KForeign issuer reportDocumentIndex
Jun 30, 2026SC 13D/AActivist / 5%+ stakeDocumentIndex
Jun 18, 20266-KForeign issuer reportDocumentIndex
Jun 17, 20266-KForeign issuer reportDocumentIndex
Jun 16, 2026424B5Offering prospectusDocumentIndex
Jun 16, 2026FWPDocumentIndex
Jun 15, 2026FWPDocumentIndex
Jun 15, 2026424B5Offering prospectusDocumentIndex
Jun 15, 20266-KForeign issuer reportDocumentIndex
Jun 8, 20266-KForeign issuer reportDocumentIndex
Jun 4, 20266-KForeign issuer reportDocumentIndex
May 11, 20266-KForeign issuer reportDocumentIndex
May 4, 20266-KForeign issuer reportDocumentIndex
Mar 31, 202620-FAnnual report (foreign)DocumentIndex
Mar 19, 20266-KForeign issuer reportDocumentIndex
Mar 12, 2026SC 13D/AActivist / 5%+ stakeDocumentIndex
Feb 27, 20266-KForeign issuer reportDocumentIndex
Feb 5, 20266-KForeign issuer reportDocumentIndex
Feb 2, 20266-KForeign issuer reportDocumentIndex
Jan 29, 20266-KForeign issuer reportDocumentIndex
Jan 7, 20266-KForeign issuer reportDocumentIndex
Jan 7, 20266-KForeign issuer reportDocumentIndex
Jan 6, 20266-KForeign issuer reportDocumentIndex
Jan 2, 20266-KForeign issuer reportDocumentIndex
Dec 23, 20256-KForeign issuer reportDocumentIndex
Dec 19, 20256-KForeign issuer reportDocumentIndex
Dec 17, 20256-KForeign issuer reportDocumentIndex
Nov 24, 20256-KForeign issuer reportDocumentIndex
Nov 20, 20256-KForeign issuer reportDocumentIndex
Nov 17, 20256-KForeign issuer reportDocumentIndex
Nov 12, 20256-KForeign issuer reportDocumentIndex
Nov 6, 20256-KForeign issuer reportDocumentIndex